Preclinical Studies for Nanoparticle-Enabled Photothermal Therapy: Progress and Challenges

Len Pagliaro

CEO

Siva Therapeutics Inc.

Chief Executive Officer – Len Pagliaro, PhD, has 18 years of experience with successful commercialization of biotechnology products, services, and licensing, following an academic career. He has managed R&D and business development teams, and brought product lines from concept through commercialization to acquisition. A small molecule oncology project he led was successfully partnered with TopoTarget, and is now in the clinic. Len managed the P&L for a business unit of Thermo Fisher Scientific selling tools for drug discovery before co-founding Siva. He is responsible for overall corporate strategy and financing.